Lars Hageroth

Mr. Lars Hageroth


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2025 in Sensors
Verified
Journal Article
Open access
PDF file
CHChristian Marinus Huber
Christian Marinus Huber
LHLars Hageroth
Lars Hageroth
NDNicole Dorsch
Nicole Dorsch
JRJohannes Ringel
Johannes Ringel
HEHelmut Ermert
Helmut Ermert
SLStefan Lyer
Stefan Lyer
Superparamagnetic iron oxide nanoparticles (SPIONs) have shown promise across a wide range of biomedical applications, including targeted drug delivery, magnetic hyperthermia, magnetic resonance imaging, and regenerative medicine. In the context of local tumor therapy (Magnetic Drug Targeting, MDT) SPIONs can be functionalized with chemotherapeutic agents and accumulated at tumor sites using an externally applied magnetic field. To achieve effective drug accumulation and therapeutic efficacy, precise positioning of the accumulation magnet relative to the tumor is essential. To address this need, we propose a dual-modality ultrasound imaging approach combining magnetomotive ultrasound (MMUS) and passive cavitation mapping (PCM). MMUS detects magnetically induced displacements to localize SPIONs embedded in elastic tissue, while PCM monitors cavitation emissions from circulating SPIONs under focused ultrasound exposure. In addition to detection, PCM has the potential to enable feedback-based control of cavitation exposure, allowing cavitation parameters to be kept within a safe regime. The dual imaging modality approach was validated using standard phantoms and a complex carotid bifurcation tumor flow phantom fabricated via 3D printing. Experimental results demonstrate the first coordinated spatiotemporal imaging of MMUS and PCM within the same anatomical model, resolving the key bottleneck of SPIONs monitoring in blood vessels/tissue. This demonstrates the strong potential of complementary MMUS and PCM imaging for monitoring in preclinical and clinical MDT settings.

13 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CHChristian Marinus Huber
Christian Marinus Huber
LHLars Hageroth
Lars Hageroth
NDNicole Dorsch
Nicole Dorsch
JRJohannes Ringel
Johannes Ringel
HEHelmut Ermert
Helmut Ermert
SLStefan Lyer
Stefan Lyer
Superparamagnetic iron oxide nanoparticles (SPIONs) have shown promise across a wide range of biomedical applications, including targeted drug delivery, magnetic hyperthermia, magnetic resonance imaging, and regenerative medicine. In the context of local tumor therapy (Magnetic Drug Targeting, MDT) SPIONs can be functionalized with chemotherapeutic agents and accumulated at tumor sites using an externally applied magnetic field. To achieve effective drug accumulation and therapeutic efficacy, precise positioning of the accumulation magnet relative to the tumor is essential. To address this need, we propose a dual-modality ultrasound imaging approach combining Magnetomotive Ultrasound (MMUS) and Passive Cavitation Mapping (PCM). MMUS detects magnetically induced tissue displacements, allowing localization of SPIONs embedded in tissue. However, MMUS is ineffective in vascular regions where no tissue displacement occurs. To overcome this, we use PCM to image circulating SPIONs, which are engineered to emit cavitation signals under focused ultrasound exposure. This complementary method enables SPIONs monitoring within tissue and flow. Validation was performed using standard phantoms and a custom-designed carotid bifurcation tumor flow phantom fabricated with 3D printing. Experimental results confirm that this hybrid strategy effectively images SPIONs in both tumor tissue and vasculature. This demonstrates the strong potential of complementary MMUS and PCM imaging for monitoring in preclinical and clinical MDT settings.